Emeis Stock Falls Below Its Moving Average and Approaches a Technical Support
The healthcare services group's stock is down mid-session, contrary to the upward trend of the SBF 120. The movement occurs in a Parisian market caught between the easing of the VIX and ongoing geopolitical tensions in the Middle East. Despite this decline, the stock maintains a comfortable lead over the year.
2.5% Decline in Session Despite a Well-Oriented SBF 120
Emeis falls 2.5% to €14.41 mid-session, while the SBF 120 gains 0.56%. The stock is at the bottom of the broader index, going against the day's strongest gains (STMicroelectronics, Atos, Worldline). The decline erases part of the stock's weekly gain, now at -4.51% over seven days. Over three months, the performance is negative at -6.31%, but the stock is still up 41.41% over the year.
Stock Falls Below the 20-Day Moving Average but Maintains a Cushion Over the 200-Day Moving Average
At €14.41, the price falls below its 20-day moving average (€14.90) by 3.29%. However, it remains above the 50-day moving average at €14.20 and the 200-day moving average at €13.86, maintaining a technical cushion of about 4% on the latter. The RSI at 51 indicates a lack of strong directional signals, while the MACD slightly slips below its signal line. The identified support at €13.71 is just over 4% below the current price and coincides with the 200-day moving average zone, now closely watched after breaking the 20-day moving average. For reference, the group had confirmed on May 7 a 6.3% organic growth for Q1 2026 and maintained its guidance for an EBITDAR increase of more than 10% for the year.
